ASQ-PHI Introduced: A Novel Benchmark Balancing Clinical Data Privacy and Search Utility
April 17, 2026
Brand Name :
Synonyms :
Class :
antiplatelet agents may enhance the adverse/toxic effect of ibritumomab tiuxetan
antiplatelet agents may enhance the adverse/toxic effect of ibritumomab tiuxetan
antiplatelet agents may enhance the adverse/toxic effect of ibritumomab tiuxetan
antiplatelet agents may enhance the adverse/toxic effect of ibritumomab tiuxetan
antiplatelet agents may enhance the adverse/toxic effect of ibritumomab tiuxetan
when both the drugs are combined, the risk or severity of adverse effects increases